Significance of data analysis in the quality control of prenatal screening for Down syndrome

被引:7
|
作者
Li, Yahong [1 ]
Zhang, Xiaojuan [1 ]
Hong, Dongyang [1 ]
Guan, Xianwei [1 ]
Lv, Shaolei [2 ]
Sun, Yun [1 ]
Jiang, Tao [1 ]
机构
[1] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Ctr Prenatal Diag, Affiliated Obstet & Gynecol Hosp, 123 Tianfei Rd, Nanjing 210004, Jiangsu, Peoples R China
[2] Zhejiang Biosan Biochem Technol Co Ltd, Hangzhou 310000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
quality control; prenatal screening; Down syndrome;
D O I
10.3892/br.2018.1078
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Dual detection of alpha-fetoprotein (AFP) and free beta-human chorionic gonadotropin (beta-HCG) is a common screening method for Down syndrome in the second trimester and its efficacy is assessed by false-positive rate (FPR). The present study aimed to investigate the effects of the bias in median multiple of the median (mMoM) values of AFP and free beta-HCG on FPR. The bias in mMoM values of AFP and free beta-HCG and the bias in mMoM values under different gestational ages and weight groups were analyzed. Median equations were adjusted, and medians in LifeCycle software were replaced by local medians. Following two adjustments of the median equations, all indices including FPR, mMoM values of markers and mMoM values under different gestational ages and weight groups generally reached an ideal state. In conclusion, abnormal bias in mMoM values may prompt aberrant application of median equations, and regular monitoring of these indicators may be important for quality control in prenatal screening.
引用
收藏
页码:447 / 453
页数:7
相关论文
共 50 条
  • [41] Providing information about prenatal screening for Down syndrome: a systematic review
    Skjoth, Mette M.
    Draborg, Eva
    Pedersen, Claus D.
    Hansen, Helle P.
    Lamont, Ronald F.
    Jorgensen, Jan S.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2015, 94 (02) : 125 - 132
  • [42] Clinical strategy study on prenatal screening and diagnostic model for Down syndrome
    Luo, Wei
    Liu, Sha
    He, Bin
    Han, Daiwen
    Yuan, Lixing
    Zhao, Kai
    Tang, Jun
    Pang, Ling
    Zou, Fene
    Liu, Jianlong
    Liu, Hongqian
    Bai, Ting
    Jing, Xiaosha
    Xia, Tianyu
    Deng, Cechuan
    Liu, Yunyun
    Cheng, Jing
    Wei, Xiang
    Xing, Lingling
    Luo, Yuan
    Zhou, Quanfang
    Zhu, Qian
    Liu, Shanling
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [43] Nuchal Translucency Thresholds in Prenatal Screening for Down Syndrome and Trisomy 18
    Miron, Pierre
    Cote, Yvan P.
    Lambert, Jean
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2009, 31 (03) : 227 - 235
  • [44] Effect of allowing for ethnic group in prenatal screening for Down's syndrome
    Watt, HC
    Wald, NJ
    Smith, D
    Kennard, A
    Densem, J
    PRENATAL DIAGNOSIS, 1996, 16 (08) : 691 - 698
  • [45] FEMUR LENGTH SHORTENING IN THE DETECTION OF DOWN SYNDROME - IS PRENATAL SCREENING FEASIBLE
    NYBERG, DA
    RESTA, RG
    HICKOK, DE
    HOLLENBACH, KA
    LUTHY, DA
    MAHONY, BS
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 162 (05) : 1247 - 1252
  • [46] Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome
    Craig, Wendy Y.
    Haddow, James E.
    Palomaki, Glenn E.
    Kelley, Richard I.
    Kratz, Lisa E.
    Shackleton, Cedric H. L.
    Marcos, Josep
    Tint, G. Stephen
    MacRae, Andrew R.
    Nowaczyk, Malgorzata J.
    Kloza, Edward M.
    Irons, Mira B.
    Roberson, Marie
    PRENATAL DIAGNOSIS, 2006, 26 (09) : 842 - 849
  • [47] PRENATAL SCREENING MARKERS FOR DOWN SYNDROME: SENSITIVITY, SPECIFICITY, POSITIVE AND NEGATIVE EXPECTED VALUE METHOD
    Durkovic, Jasmina
    Ubavic, Milan
    Durkovic, Milica
    Kis, Tibor
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2018, 37 (01) : 62 - 66
  • [48] What factors influence health professionals to use decision aids for Down syndrome prenatal screening?
    Lepine, Johanie
    Portocarrero, Maria Esther Leiva
    Delanoe, Agathe
    Robitaille, Hubert
    Levesque, Isabelle
    Rousseau, Francois
    Wilson, Brenda J.
    Giguere, Anik M. C.
    Legare, France
    BMC PREGNANCY AND CHILDBIRTH, 2016, 16
  • [49] Offer and uptake of prenatal screening for Down syndrome in women from different social and ethnic backgrounds
    Rowe, Rachel
    Puddicombe, David
    Hockley, Christine
    Redshaw, Maggie
    PRENATAL DIAGNOSIS, 2008, 28 (13) : 1245 - 1250
  • [50] Clinical application of inhibin A measurement: Prenatal serum screening for Down syndrome
    Lambert-Messerlian, GM
    Canick, JA
    SEMINARS IN REPRODUCTIVE MEDICINE, 2004, 22 (03) : 235 - 242